AFX Introducer Recall Issued Due to Risk of Dilator Breaking During Use

|

Reports of dilators breaking during medical procedures has resulted in the recall of AFX Introducer Systems, which are used to help insert catheters and other medical devices into blood vessels.  

The FDA announced a Class I AFX Introducer System recall this week after reports of broken dilators. The class I designation means that the FDA believes that the use of this product could cause serious injury or death.

The manufacturer, Endologix, Inc., originally sent out an URGENT MEDICAL DEVICE RECALL NOTICE letter to customers on May 13. The letter urged customers not to use or further distribute the recalled system. The FDA did not indicate whether the reported incidents had resulted in serious injury or death for any patients.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The recall affects the AFX Introducer System, model number S17-45, from lot numbers 1079840, 1079843, 1079844, and 1079845. The affected systems were distributed and manufactured from April 1, 2013 through April 30, 2013 and were distributed in Florida, Indiana, Michigan, New Hampshire, New Jersey and New York.

Endologix has instructed customers to share information about the recall with physicians who perform procedures using the AFC Introducer System a their facilities. The company said it plans to notify all affected customers by phone to confirm the device is present and to arrange for the recalled system’s return.

Customers with questions can call (800) 983-2284.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Lawsuits over Ozempic and Wegovy vision loss will be consolidated for pretrial proceedings in New Jersey, separate from claims involving gastrointestinal injuries.
Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks.
A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027.